| Project/Area Number |
15K09840
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Psychiatric science
|
|---|
| Research Institution | Sapporo Medical University |
|---|
Principal Investigator |
Kawamata Jun 札幌医科大学, 医学部, 准教授 (60360814)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
下濱 俊 札幌医科大学, 医学部, 教授 (60235687)
|
|---|
| Project Period (FY) |
2015-04-01 – 2018-03-31
|
| Project Status |
Completed (Fiscal Year 2017)
|
| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
|---|
| Keywords | アルツハイマー病 / BPSD / プレセニリン１ / トランスジェニックマウス / CRISPR/Cas9 / アルツハイマー |
|---|
| Outline of Final Research Achievements |
We report the familial Alzheimer pedigree carrying a novel mutation, three bases deletion, which results in one amino acid deletion of PS1 (Psen1 delta p.277). To establish the adequate animal model of AD especially presenting BPSD-like symptoms, we planned to make the transgenic mice harboring the mutation using CRISPR/Cas9 method. Even after injecting more than 200 times, no living mutant mouse was obtained. Remodeling guide RNA(crRNA) results in successfully establishing the transgenic mice, which will enable the neuropathological and behavioral analysis after aging of these transgenic mice, both heterozygote and possibly homozygote.
|
